35010-96-9

Basic information

• Product Name: Z-PRO-GLY-NH2
• Synonyms: Z-PRO-GLY-NH2;Z-Pro-Gly-NH2≥ 99% (TLC)
• CAS NO: 35010-96-9
• Molecular Formula: C₁₅H₁₉N₃O₄
• Molecular Weight: 305.33
• Mol File: 35010-96-9.mol
• Article Data: 5

Chemical Properties

• Melting Point: 120 °C
• Boiling Point: 604.889 °C at 760 mmHg
• Flash Point: 319.626 °C
• Appearance: /
• Density: 1.297 g/cm³
• Storage Temp.: -15°C
• PKA: 14.49±0.20(Predicted)
• CAS DataBase Reference: Z-PRO-GLY-NH2(CAS DataBase Reference)
• NIST Chemistry Reference: Z-PRO-GLY-NH2(35010-96-9)
• EPA Substance Registry System: Z-PRO-GLY-NH2(35010-96-9)

Safety Data

• Hazardous Substances Data: 35010-96-9(Hazardous Substances Data)

Usage

Chemical Properties

White powder

Upstream product

• 3304-59-4 N-benzyloxycarbonyl-L-proline p-nitrophenyl ester 
• 1668-10-6 glycinamide hydrochloride 
• 1148-11-4 N-Benzyloxycarbonyl-L-proline 
• 61058-42-2 Z-Pro-Gly-OMe 

Downstream Products

• 61058-42-2 Z-Pro-Gly-OMe 
• 2766-18-9 N-carbobenzoxyprolylglycine 
• 97985-95-0 {(S)-1-[(S)-1-{[((S)-1-{(S)-1-[(S)-2-(Carbamoylmethyl-carbamoyl)-pyrrolidine-1-carbonyl]-4-guanidino-butylcarbamoyl}-3-methyl-butylcarbamoyl)-methyl]-carbamoyl}-2-(4-hydroxy-phenyl)-ethylcarbamoyl]-2-hydroxy-ethyl}-carbamic acid benzyl ester 
• 97985-97-2 amide of benzyloxycarbonylarginylprolylglycine 
• 51776-33-1 luteinizing hormone-releasing hormone (4-10) 
• 132478-01-4 (S)-1-[(S)-2-((S)-2-{(R)-2-[(S)-2-((S)-2-Amino-3-hydroxy-propionylamino)-3-(4-hydroxy-phenyl)-propionylamino]-3-phenyl-propionylamino}-4-methyl-pentanoylamino)-5-guanidino-pentanoyl]-pyrrolidine-2-carboxylic acid carbamoylmethyl-amide 
• 77659-17-7 Z-Pro-Ser-Tyr-D-Ala-Leu-(O₂N)Arg-Pro-Gly-NH₂ 
• 77659-12-2 Z-D-Ala-Leu-(O₂N)Arg-Pro-Gly-NH₂ 
• 41271-84-5 Z-Leu-(O₂N)Arg-Pro-Gly-NH₂ 
• 41271-83-4 Z-(O₂N)Arg-Pro-Gly-NH₂ 
• 136315-46-3 N^α-Benzyloxycarbonyl-L-leucyl-L-arginyl-L-prolylglycine amide acetate sesquihydrate 

Relevant articles and documents

PEPTIDE DEFORMYLASE INHIBITORS

Novel PDF inhibitors of Formula (I), pharmaceutical compositions thereof and their use in treating bacterial infections are described.

Large-Scale Synthesis of Mammalian Gonadoliberin without Protection of Side-Chain Functions

A simple, large-scale preparation of mammalian gonadoliberin was elaborated using classical solution methods without protecting side-chain functions.At the final stage, a hexapeptide segment was condensed with the corresponding tetrapeptide and the obtain

SYNTHESIS OF 3(NH2); Pro3; D-Ala6>- and 2(NO2); Pro3; D-Ala6>LULIBERINS

In order to study the influence of substituents of the aromatic ring of D-phenylalanine on the inhibiting capacity of luliberian analogs, we have synthesized two new analogs: 2; Pro3; D-Ala6>- and